当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Letter: evaluation and proposed re-classification of HCC prediction model in patients with chronic hepatitis C genotype 4
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-12-30 , DOI: 10.1111/apt.16704 Gamal Shiha 1, 2 , Nabiel N H Mikhail 1, 3 , Reham Soliman 4
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-12-30 , DOI: 10.1111/apt.16704 Gamal Shiha 1, 2 , Nabiel N H Mikhail 1, 3 , Reham Soliman 4
Affiliation
This article is linked to Tahata et al papers. To view these articles, visit https://doi.org/10.1111/apt.16632 and https://doi.org/10.1111/apt.16721
中文翻译：
信函：慢性丙型肝炎基因4型患者HCC预测模型的评估和重新分类建议
本文链接到 Tahata 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.16632 和 https://doi.org/10.1111/apt.16721
更新日期：2021-12-31
中文翻译：
信函：慢性丙型肝炎基因4型患者HCC预测模型的评估和重新分类建议
本文链接到 Tahata 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.16632 和 https://doi.org/10.1111/apt.16721
京公网安备 11010802027423号